SGLT2 inhibitor canagliflozin reduces visceral adipose tissue in db/db mice by modulating AMPK/KLF4 signaling and regulating mitochondrial dynamics to induce browning
Jingru Qu, Lei Tian, Man Zhang, Bei Sun, Liming Chen
Topics & Concepts
EndocrinologyInternal medicineAdipose tissueAMPKWhite adipose tissueAdipocyteKLF4Brown adipose tissueCanagliflozinAdipogenesisThermogenesisBiologyChemistryCell biologyProtein kinase AMedicineType 2 diabetesKinaseEmbryonic stem cellDiabetes mellitusSOX2BiochemistryGeneAdipose Tissue and MetabolismPancreatic function and diabetesMetabolism, Diabetes, and Cancer